EFFECTS OF ORAL-ADMINISTRATION OF DIFFERENT DOSES OF PURIFIED MICRONIZED FLAVONOID FRACTION ON MICROVASCULAR REACTIVITY AFTER ISCHAEMIA REPERFUSION IN THE HAMSTER-CHEEK POUCH/
E. Bouskela et al., EFFECTS OF ORAL-ADMINISTRATION OF DIFFERENT DOSES OF PURIFIED MICRONIZED FLAVONOID FRACTION ON MICROVASCULAR REACTIVITY AFTER ISCHAEMIA REPERFUSION IN THE HAMSTER-CHEEK POUCH/, British Journal of Pharmacology, 122(8), 1997, pp. 1611-1616
1 The effects of a purified micronized flavonoid fraction (S5682) on m
ean internal diameter and blood flow of arterioles and venules, as wel
l as the functional capillary density (FCD) were evaluated in the hams
ter cheek pouch microvasculature before and after 90 min of total isch
aemia. 2 Male hamsters were treated for ten days, twice a day, with or
al doses of S5682 (5, 20, 80 and 160 mg kg(-1) day(-1)) or placebo (10
% lactose solution). The cheek pouch preparation was placed under an i
ntravital microscope coupled to a closed circuit TV system. Local isch
aemia was obtained by a cuff mounted around the neck of the everted po
uch where it leaves the mouth of the hamster. 3 Measurements were perf
ormed before ischaemia, at the onset of reperfusion and 10, 20, 30, 45
and 60 min thereafter. Diameters were measured by means of an image s
hearing device. Red blood cell (RBC) velocity was analysed by use of t
he dual-slit photometric technique. Blood flow was calculated from dia
meters and RBC velocities. FCD, defined as the number of capillaries w
ith flowing blood per held of observation, was also assessed. 4 During
reperfusion, placebo-treated animals showed a significant vasodilatat
ion, a decrease in blood how and FCD and S5682-treated animals showed
a clear trend, dose-dependent, towards maintaining these parameters cl
oser to the value found before ischaemia. 5 In conclusion, our results
indicate that S5682 improves the microvascular reactivity and FCD aft
er ischaemia/reperfusion. These data suggest that S5682 could function
as an antioxidant, which may explain its beneficial therapeutic effec
t in chronic venous insufficiency where oxidative stress is involved i
n the pathological mechanism.